Biostats
Junior

India,
2018-03-29 12:39

Posting: # 18613
Views: 2,782
 

 bioequivalence criteria for NTID [Regulatives / Guidelines]

Dear All,

As per Draft Guidance on Warfarin Sodium bioequivalence criteria for NTID as
  1. Every study should pass the scaled average bioequivalence limits and
  2. Also regular unscaled bioequivalence limits of 80.00-125.00%.
  3. the upper limit of the 90% equal-tails confidence interval for σwT/σwR is less than or equal to 2.5
My understanding for 1 and 2 criteria as below,
  1. The 95% upper confidence bound for (YTYR)2θs2wR must be ≤ 0 and the point estimate of the Test/Reference geometric mean ratio must fall within 80.00 – 125.00%. (scaled average bioequivalence limits)
  2. 90% confidence interval should lies within 80–125% (unscaled bioequivalence limits)
Is this correct? Please guide me to understand the bioequivalence criteria of NTI drugs.

Thanks in advanced.
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-03-29 14:27

@ Biostats
Posting: # 18615
Views: 2,444
 

 bioequivalence criteria for NTID

Hi Biostats,

your understanding of 1 & 2 is correct. Don’t forget #3!

» Please guide me to understand the bioequivalence criteria of NTI drugs.

Can you be more specific?

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Biostats
Junior

India,
2018-03-30 06:25

@ Helmut
Posting: # 18623
Views: 2,373
 

 bioequivalence criteria for NTID

Thanks Sir,

Is it mandatory to check - point estimate of the Test/Reference geometric mean ratio must fall within 80.00 - 125.00%?


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]
Helmut
Hero
avatar
Homepage
Vienna, Austria,
2018-03-30 11:19

@ Biostats
Posting: # 18624
Views: 2,384
 

 GMR not relevant in ABE

Hi Biostats

» Is it mandatory to check - point estimate of the Test/Reference geometric mean ratio must fall within 80.00 - 125.00%?

See your condition #2 and the guidance

Every study should pass the scaled average bioequivalence limits and also regular unscaled bioequivalence limits of 80.00–125.00%.


What do you think where the GMR lies if a study passes ABE? It is only nice to know (unless you are concerned about this discussion). If a study fails ABE, the location of the GMR is even less relevant. Hence, the FDA does not ask for it.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
jag009
Hero

NJ,
2018-03-29 17:20

@ Biostats
Posting: # 18618
Views: 2,396
 

 bioequivalence criteria for NTID

» Please guide me to understand the bioequivalence criteria of NTI drugs.

This might help. A nice article from my professor...

Endrenyi - NTI

John
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,271 posts in 4,099 threads, 1,315 registered users;
online 12 (0 registered, 12 guests [including 6 identified bots]).

It’s easy to lie with statistics;
it is easier to lie without them.    Frederick Mosteller

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5